未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis Zanubrutinib与Orelabrutinib在R/R MCL患者中的疗效间接比较:一项扩展随访分析 Deng, LJ; Song, YQ; Zhou, KS; Li, DJ; Hu, JD; Zou, DH; Gao, SJ; Yang, HY; Zhang, HL; Ji, J; Xu, W; Feng, R; Jin, J; Lv, FF; Fang, C; Xu, S; Zhu, J 分享 收藏
分享 收藏
Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial Liu, Xiaochun; Luo, Yang; Chen, Xingyu; Wu, Mingyang; Xu, Xiaoqiang; Tian, Jingru; Gao, Yingxia; Zhu, Jun; Wang, Zhifeng; Zhou, Yuan; Zhang, Yu; Wang, Xiaokai; Li, Wei; Lu, Qianjin; Yao, Xu 分享 收藏
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer Li, Ning; Qiu, Meng; Zhang, Yanqiao; Yang, Mudan; Lu, Linzhi; Li, Wei; Ma, Yuntao; Hou, Xiaoming; Sun, Guoping; Cai, Mingquan; Wang, Jingran; Lu, Jianwei; Zhong, Diansheng; Huo, Zhibin; Zhang, Jingdong; Yin, Xianli; Deng, Jun; Liu, Zimin; Pan, Hongming; Chen, Ye; Yang, Futang; Yu, Haoyu; Li, Jing; Wang, Qingyu; Zhu, Jun; Li, Jin 分享 收藏
Preliminary results from a phase Ib study of amulirafusp alfa (IMM0306) in combination with lenalidomide in patients with relapsed or refractory CD20-positive B-cell nonHodgkin's lymphoma Ib期研究初步结果:评估amulirafusp alfa(IMM0306)联合lenalidomide治疗复发或难治性CD20阳性B细胞非霍奇金淋巴瘤患者的疗效。 Deng, L.; Song, Y.; Liu, Y.; Lin, N.; Yao, Z.; Zhang, J.; Meng, W.; Wang, Z.; Lu, Q.; Tian, W.; Zhu, J. 分享 收藏
PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma Hu, Dingyao; Cao, Jiaowu; Yu, Hui; Ding, Ning; Mi, Lan; Ye, Yingying; Li, Miaomiao; Wang, Dedao; Wu, Jiajin; Wang, Xiaogan; Song, Yuqin; Zhu, Jun; Ping, Lingyan 分享 收藏
Sorafenib sensitization in tumor therapy by iron overload and AMPK activation Zhu, Jun; Zhao, Shoujie; Zhu, Yejing; Ma, Shouzheng; Han, Tenghui; Xu, Fenghua; Li, Huichen; Wang, Bo; Guo, Zhixiong; Chen, Da; Qu, Yongquan; Tian, Zhimin; Zhao, Junlong; Liu, Lei 分享 收藏
分享 收藏
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial Camrelizumab联合吉西他滨和奥沙利铂治疗复发或难治性经典霍奇金淋巴瘤: II期试验 Liu, Yanfei; Ping, Lingyan; Song, Yuqin; Tang, Yongjing; Zheng, Wen; Liu, Weiping; Ying, Zhitao; Zhang, Chen; Wu, Meng; Feng, Feier; Lin, Ningjing; Tu, Meifeng; Zhu, Jun; Xie, Yan 分享 收藏
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors Song, Yuqin; Cao, Junning; Zhang, Qingyuan; Li, Caixia; Qiu, Lugui; Qi, Junyuan; Zhang, Huilai; Li, Wenyu; Liu, Lihong; Jing, Hongmei; Zhou, Keshu; Zhang, Weijing; Zhang, Liling; Li, Daqi; Zou, Liqun; Yang, Haiyan; Qian, Wenbin; Zhou, Hui; Hu, Jianda; Yin, Hongyan; Fu, Sisi; Fan, Songhua; Xu, Qian; Wang, Jian; Jia, Xiaoyun; Dai, Guangxiu; Su, Weiguo; Zhu, Jun 分享 收藏
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma Qi, Fei; Wei, Yuce; Wu, Meng; Sun, Yan; Xie, Yan; Lin, Ningjing; Liu, Weiping; Wang, Weihu; Song, Yuqin; Zhu, Jun 分享 收藏